EPIDERMOLYSIS BULLOSA DYSTROPHICA

Clinical trials for EPIDERMOLYSIS BULLOSA DYSTROPHICA explained in plain language.

Never miss a new study

Get alerted when new EPIDERMOLYSIS BULLOSA DYSTROPHICA trials appear

Sign up with your email to follow new studies for EPIDERMOLYSIS BULLOSA DYSTROPHICA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 2 Completed 1

Experimental drug tested for deadly skin cancer in rare disease patients

Disease control Completed

This small, early-stage study tested an experimental cancer drug called rigosertib in adults with a rare, severe skin condition (RDEB) who had developed an aggressive, hard-to-treat skin cancer. The main goals were to see if the drug could shrink the cancer and to check how safe …

Matched conditions: EPIDERMOLYSIS BULLOSA DYSTROPHICA

Phase: PHASE1, PHASE2 • Sponsor: Prof. Johann Bauer • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

EPIDERMOLYSIS BULLOSA DYSTROPHICA

Get alerted when new EPIDERMOLYSIS BULLOSA DYSTROPHICA trials appear

Experimental drug tested for deadly skin cancer in rare disease patients